Mettler-Toledo International, Inc. (NYSE:MTD) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Mettler-Toledo International, Inc. (NYSE:MTD) have received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the firm, Marketbeat reports. Six analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $1,463.75.

MTD has been the topic of a number of analyst reports. Wells Fargo & Company upped their price target on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. The Goldman Sachs Group started coverage on shares of Mettler-Toledo International in a research note on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 price objective for the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Mettler-Toledo International in a report on Monday, December 29th. Jefferies Financial Group upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and upped their target price for the stock from $1,400.00 to $1,450.00 in a research note on Friday. Finally, Bank of America upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target on the stock in a report on Monday, December 15th.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the sale, the chief financial officer directly owned 5,288 shares in the company, valued at approximately $7,456,714.56. This trade represents a 13.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.77% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the business. EverSource Wealth Advisors LLC boosted its position in shares of Mettler-Toledo International by 2.4% during the third quarter. EverSource Wealth Advisors LLC now owns 294 shares of the medical instruments supplier’s stock valued at $361,000 after buying an additional 7 shares during the last quarter. Allworth Financial LP raised its position in Mettler-Toledo International by 6.1% in the 3rd quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier’s stock worth $149,000 after buying an additional 7 shares during the last quarter. GAMMA Investing LLC lifted its stake in Mettler-Toledo International by 1.6% during the 3rd quarter. GAMMA Investing LLC now owns 510 shares of the medical instruments supplier’s stock valued at $626,000 after acquiring an additional 8 shares during the period. Versant Capital Management Inc lifted its stake in Mettler-Toledo International by 42.1% during the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after acquiring an additional 8 shares during the period. Finally, Valeo Financial Advisors LLC boosted its holdings in shares of Mettler-Toledo International by 4.0% during the 3rd quarter. Valeo Financial Advisors LLC now owns 207 shares of the medical instruments supplier’s stock valued at $254,000 after acquiring an additional 8 shares during the last quarter. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Stock Up 1.3%

MTD stock opened at $1,205.77 on Monday. The business has a 50 day moving average of $1,351.42 and a 200 day moving average of $1,366.03. The firm has a market cap of $24.42 billion, a PE ratio of 28.63, a price-to-earnings-growth ratio of 2.53 and a beta of 1.43. Mettler-Toledo International has a twelve month low of $946.69 and a twelve month high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, topping the consensus estimate of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The business had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the previous year, the company posted $12.41 earnings per share. The company’s revenue for the quarter was up 8.1% compared to the same quarter last year. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. On average, research analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.